Cargando…

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration

Detalles Bibliográficos
Autores principales:	Singh, Sunil Kumar, Deka, Satyen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134543/ https://www.ncbi.nlm.nih.gov/pubmed/25136244 http://dx.doi.org/10.4103/0974-620X.137178

Ejemplares similares

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Shaikh, Saad, et al.
Publicado: (2007)

Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection
por: Fujii, Ayaka, et al.
Publicado: (2014)

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
por: Deka, Satyen, et al.
Publicado: (2009)

Retinal pigment epithelial tear following intravitreal injection of brolucizumab
por: Ashkenazy, Noy, et al.
Publicado: (2021)

Intravitreal gas injection with prone positioning for giant retinal pigment epithelial tear
por: Singh, Deependra Vikram, et al.
Publicado: (2018)

Incidence of Retinal Pigment Epithelial Tears and Associated Risk Factors After Treatment of Age-Related Macular Degeneration with Intravitreal Anti-VEGF Injections§
por: Empeslidis, Theodoros, et al.
Publicado: (2014)

Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
por: Gonzalez, Andres, et al.
Publicado: (2017)

High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
por: Lee, Dong Kyu, et al.
Publicado: (2016)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon, Sohee, et al.
Publicado: (2014)

Retinal pigment epithelium tear after intravitreal aflibercept injection
por: Saito, Masaaki, et al.
Publicado: (2013)

Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
por: Tripathy, Koushik
Publicado: (2018)

Massive Exudative Retinal Detachment Following Photodynamic Therapy and Intravitreal Bevacizumab Injection in Retinal Capillary Hemangioma
por: Kim, Hyeong Min, et al.
Publicado: (2015)

Response to comment on “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
por: Storch, Marcus, et al.
Publicado: (2018)

Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab
por: Chalam, Kakarla V, et al.
Publicado: (2011)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration
por: Figurska, Małgorzata
Publicado: (2012)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki, Hiroyuki, et al.
Publicado: (2017)

Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment
por: Zhao, Chun, et al.
Publicado: (2016)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

Slow progression of exudative age related macular degeneration associated with hypertrophy of the retinal pigment epithelium
por: Stern, Jeffrey, et al.
Publicado: (2014)

Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes
por: Figurska, Małgorzata, et al.
Publicado: (2011)

AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study
por: Blanco-Garavito, Rocio, et al.
Publicado: (2018)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Prospective Study of Vessel Density by Optical Coherence Tomography Angiography After Intravitreal Bevacizumab in Exudative Age-Related Macular Degeneration
por: Cennamo, Gilda, et al.
Publicado: (2019)

Large retinal pigment epithelium rip following serial intravitreal injection of avastin in a large fibrovascular pigment epithelial detachment
por: Subramanyam, Anand, et al.
Publicado: (2007)

Retinal Detachment with Macular Hole Following Combined Photodynamic Therapy and Intravitreal Bevacizumab Injection
por: Chung, Eun Jee, et al.
Publicado: (2007)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
por: Damkondwar, Deepali R, et al.
Publicado: (2022)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
por: Torabi, Hamidreza, et al.
Publicado: (2018)

Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
por: Karampelas, Michael, et al.
Publicado: (2020)

A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis
por: Singh, Rishi P, et al.
Publicado: (2014)

Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment
por: Storch, Marcus Werner, et al.
Publicado: (2017)

Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007)

Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab
por: Perdicchi, Andrea, et al.
Publicado: (2015)

Comparison of single injection of intravitreal triamcinolone versus single injection of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusions with regard to changes in best corrected visual acuity and central macular thickness in the short term
por: Kelkar, Aditya S., et al.
Publicado: (2009)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections
por: Shin, Yong Un, et al.
Publicado: (2017)

Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration
por: Kim, Moosang, et al.
Publicado: (2016)

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
por: Hamid, Mohamed A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_srdjm9q8u00vh58j4mqt8ngo1m